SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways
Jian Deng(Shandong University), Pei‐Hui Wang(Shandong University), Chengjiang Gao(Shandong University), Yunyun Jin(Sun Yat-sen University), Lulu Han(Shandong University), Jing Zhang(Zhejiang Chinese Medical University), Yi Zheng(Shandong University), Shengnan Zheng(Shandong University), Mei‐Ling Nan(Shandong University)
Cited by 37
Related Papers
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
|Cellular and Molecular Immunology|2020|376
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling
|Signal Transduction and Targeted Therapy|2020|301
TRIM26 Negatively Regulates Interferon-β Production and Antiviral Response through Polyubiquitination and Degradation of Nuclear IRF3
|PLoS Pathogens|2015|185
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules
|Signal Transduction and Targeted Therapy|2022|175